Rocaltrol® soft capsules
Rocaltrol® soft capsules is indicated, in general, in all diseases related to inability of renal synthesis of calcitriol, such as:
– Renal osteodystrophy, in patients with chronic renal insufficiency and more so if they are undergoing haemodialysis.
– Post-surgical hypoparathyroidism.
– Idiopathic hypoparathyroidism.
– Pseudohypoparathyroidism.
– Vitamin D-dependent rickets.
– Vitamin D-resistant hypophosphatemic rickets.
– Osteomalacia
– Pre-surgical treatment in primary hyperparathyroidism, to minimise postoperative hypocalcaemia.
Access technical file ROCALTROL® SOFT CAPSULESRocaltrol® soft capsules
Ownership: Atnahs Pharma Netherlands B.V.
Comercialized by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative.
Technical file: https://cima.aemps.es/cima/dochtml/ft/55973/FT_55973.html
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.
